We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Simple Breath Test Aids Type 1 Diabetes Early Diagnosis

By LabMedica International staff writers
Posted on 08 Dec 2014
Print article
Image: The AirSense is a mass spectrometer based on the patented Ion-Molecule Reaction (IMR-MS) and can be used for a broad field of applications (Photo courtesy of V&F).
Image: The AirSense is a mass spectrometer based on the patented Ion-Molecule Reaction (IMR-MS) and can be used for a broad field of applications (Photo courtesy of V&F).
A chemical marker has been identified for type 1 diabetes in the breath of children who are unaware they have the condition until they develop diabetic ketoacidosis, a potentially life-threatening complication and a breath test could pave the way to allow early diagnosis.

The symptoms of the diabetes mellitus type 1, which include increased thirst and urination, fatigue and weight loss, can be mistaken for symptoms of other disorders and some cases where type 1 diabetes is misdiagnosed in children. A recent study found that between 2001 and 2009, incidence of type 1 diabetes among children aged less than 9 years rose by 21%.

Biochemists at the University of Oxford (UK) collected breath samples from 113 children and adolescents aged 7 to 18 years that had been diagnosed with type 1 diabetes. The team measured levels of acetone and another ketone called isoprene in the participants' breath and compared them with ketone and glucose levels in the blood, measurements of which were taken at the same time as breath samples were collected.

The patients blew through a tube and a bacterial filter into a specially constructed 100 mL syringe which had the aim of ensuring that the gases collected were end tidal. The sealed bags were analyzed by means of a soft-ionization mass spectrometer (V & F Airsense; Absam, Austria). Acetone, isoprene and carbon dioxide concentrations were measured, with the instrument standardized for its sensitivity to these compounds by using previously calibrated gas samples. Each patient provided blood for an HbA1c measurement and had capillary blood glucose and β hydroxybutyrate (BHB) levels measured using a FreeStyle Optium meter (Abbott, Maidenhead, UK).

The investigators found increased levels of acetone in the breath of the participants who also had increased levels of a ketone called β hydroxybutyrate in their blood. The team found a weak association between increased breath acetone and increased blood glucose but concluded that single breath measurements of acetone do not provide a good measure of blood glucose levels in this cohort. The team has already produced a prototype of a small hand-held device to measure ketone levels in the breath, which is currently being tested in clinical trials.

Gus Hancock, PhD, a professor of chemistry and a senior author of the study said, “Our results have shown that it is realistically possible to use measurements of breath acetone to estimate blood ketones. If the relationship between breath acetone and blood ketone levels is true at higher levels of ketones, a simple breath test could assist with the management of sick days in children with diabetes, preventing hospital admissions by providing a warning of the possible development of diabetic ketoacidosis (DKA).” The study was published on November 25, 2014, in the Journal of Breath Research.

Related Links:

University of Oxford
V & F Airsense
Abbott 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.